Request for Covid-19 Impact Assessment of this Report
The United States Plasma Derived Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Plasma Derived Drugs market, reaching US$ million by the year 2028. As for the Europe Plasma Derived Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Plasma Derived Drugs players cover Grifols, S.A., Octapharma, Antares Pharma, and CSL Limited, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Derived Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Immunoglobulins
Albumins
Clotting Factors
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Speciality Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Grifols, S.A.
Octapharma
Antares Pharma
CSL Limited
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasma Derived Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Plasma Derived Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Plasma Derived Drugs by Country/Region, 2017, 2022 & 2028
2.2 Plasma Derived Drugs Segment by Type
2.2.1 Immunoglobulins
2.2.2 Albumins
2.2.3 Clotting Factors
2.2.4 Others
2.3 Plasma Derived Drugs Sales by Type
2.3.1 Global Plasma Derived Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Plasma Derived Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Plasma Derived Drugs Sale Price by Type (2017-2022)
2.4 Plasma Derived Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Speciality Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Diagnostic Centers
2.4.5 Others
2.5 Plasma Derived Drugs Sales by Application
2.5.1 Global Plasma Derived Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Plasma Derived Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Plasma Derived Drugs Sale Price by Application (2017-2022)
3 Global Plasma Derived Drugs by Company
3.1 Global Plasma Derived Drugs Breakdown Data by Company
3.1.1 Global Plasma Derived Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Plasma Derived Drugs Sales Market Share by Company (2020-2022)
3.2 Global Plasma Derived Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Plasma Derived Drugs Revenue by Company (2020-2022)
3.2.2 Global Plasma Derived Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Plasma Derived Drugs Sale Price by Company
3.4 Key Manufacturers Plasma Derived Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma Derived Drugs Product Location Distribution
3.4.2 Players Plasma Derived Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Plasma Derived Drugs by Geographic Region
4.1 World Historic Plasma Derived Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Plasma Derived Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Plasma Derived Drugs Annual Revenue by Geographic Region
4.2 World Historic Plasma Derived Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Plasma Derived Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Plasma Derived Drugs Annual Revenue by Country/Region
4.3 Americas Plasma Derived Drugs Sales Growth
4.4 APAC Plasma Derived Drugs Sales Growth
4.5 Europe Plasma Derived Drugs Sales Growth
4.6 Middle East & Africa Plasma Derived Drugs Sales Growth
5 Americas
5.1 Americas Plasma Derived Drugs Sales by Country
5.1.1 Americas Plasma Derived Drugs Sales by Country (2017-2022)
5.1.2 Americas Plasma Derived Drugs Revenue by Country (2017-2022)
5.2 Americas Plasma Derived Drugs Sales by Type
5.3 Americas Plasma Derived Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma Derived Drugs Sales by Region
6.1.1 APAC Plasma Derived Drugs Sales by Region (2017-2022)
6.1.2 APAC Plasma Derived Drugs Revenue by Region (2017-2022)
6.2 APAC Plasma Derived Drugs Sales by Type
6.3 APAC Plasma Derived Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Plasma Derived Drugs by Country
7.1.1 Europe Plasma Derived Drugs Sales by Country (2017-2022)
7.1.2 Europe Plasma Derived Drugs Revenue by Country (2017-2022)
7.2 Europe Plasma Derived Drugs Sales by Type
7.3 Europe Plasma Derived Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Plasma Derived Drugs by Country
8.1.1 Middle East & Africa Plasma Derived Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Plasma Derived Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Plasma Derived Drugs Sales by Type
8.3 Middle East & Africa Plasma Derived Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma Derived Drugs
10.3 Manufacturing Process Analysis of Plasma Derived Drugs
10.4 Industry Chain Structure of Plasma Derived Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma Derived Drugs Distributors
11.3 Plasma Derived Drugs Customer
12 World Forecast Review for Plasma Derived Drugs by Geographic Region
12.1 Global Plasma Derived Drugs Market Size Forecast by Region
12.1.1 Global Plasma Derived Drugs Forecast by Region (2023-2028)
12.1.2 Global Plasma Derived Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma Derived Drugs Forecast by Type
12.7 Global Plasma Derived Drugs Forecast by Application
13 Key Players Analysis
13.1 Grifols, S.A.
13.1.1 Grifols, S.A. Company Information
13.1.2 Grifols, S.A. Plasma Derived Drugs Product Offered
13.1.3 Grifols, S.A. Plasma Derived Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Grifols, S.A. Main Business Overview
13.1.5 Grifols, S.A. Latest Developments
13.2 Octapharma
13.2.1 Octapharma Company Information
13.2.2 Octapharma Plasma Derived Drugs Product Offered
13.2.3 Octapharma Plasma Derived Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Octapharma Main Business Overview
13.2.5 Octapharma Latest Developments
13.3 Antares Pharma
13.3.1 Antares Pharma Company Information
13.3.2 Antares Pharma Plasma Derived Drugs Product Offered
13.3.3 Antares Pharma Plasma Derived Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Antares Pharma Main Business Overview
13.3.5 Antares Pharma Latest Developments
13.4 CSL Limited
13.4.1 CSL Limited Company Information
13.4.2 CSL Limited Plasma Derived Drugs Product Offered
13.4.3 CSL Limited Plasma Derived Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 CSL Limited Main Business Overview
13.4.5 CSL Limited Latest Developments
14 Research Findings and Conclusion
Table 1. Plasma Derived Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Plasma Derived Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Immunoglobulins
Table 4. Major Players of Albumins
Table 5. Major Players of Clotting Factors
Table 6. Major Players of Others
Table 7. Global Plasma Derived Drugs Sales by Type (2017-2022) & (K Units)
Table 8. Global Plasma Derived Drugs Sales Market Share by Type (2017-2022)
Table 9. Global Plasma Derived Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Plasma Derived Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global Plasma Derived Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Plasma Derived Drugs Sales by Application (2017-2022) & (K Units)
Table 13. Global Plasma Derived Drugs Sales Market Share by Application (2017-2022)
Table 14. Global Plasma Derived Drugs Revenue by Application (2017-2022)
Table 15. Global Plasma Derived Drugs Revenue Market Share by Application (2017-2022)
Table 16. Global Plasma Derived Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Plasma Derived Drugs Sales by Company (2020-2022) & (K Units)
Table 18. Global Plasma Derived Drugs Sales Market Share by Company (2020-2022)
Table 19. Global Plasma Derived Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Plasma Derived Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global Plasma Derived Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Plasma Derived Drugs Producing Area Distribution and Sales Area
Table 23. Players Plasma Derived Drugs Products Offered
Table 24. Plasma Derived Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Plasma Derived Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Plasma Derived Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Plasma Derived Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Plasma Derived Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Plasma Derived Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Plasma Derived Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Plasma Derived Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Plasma Derived Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Plasma Derived Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Americas Plasma Derived Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas Plasma Derived Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Plasma Derived Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas Plasma Derived Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Americas Plasma Derived Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas Plasma Derived Drugs Sales by Application (2017-2022) & (K Units)
Table 42. Americas Plasma Derived Drugs Sales Market Share by Application (2017-2022)
Table 43. APAC Plasma Derived Drugs Sales by Region (2017-2022) & (K Units)
Table 44. APAC Plasma Derived Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC Plasma Derived Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Plasma Derived Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC Plasma Derived Drugs Sales by Type (2017-2022) & (K Units)
Table 48. APAC Plasma Derived Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC Plasma Derived Drugs Sales by Application (2017-2022) & (K Units)
Table 50. APAC Plasma Derived Drugs Sales Market Share by Application (2017-2022)
Table 51. Europe Plasma Derived Drugs Sales by Country (2017-2022) & (K Units)
Table 52. Europe Plasma Derived Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe Plasma Derived Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Plasma Derived Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe Plasma Derived Drugs Sales by Type (2017-2022) & (K Units)
Table 56. Europe Plasma Derived Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe Plasma Derived Drugs Sales by Application (2017-2022) & (K Units)
Table 58. Europe Plasma Derived Drugs Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Plasma Derived Drugs Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Plasma Derived Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Plasma Derived Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Plasma Derived Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Plasma Derived Drugs Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Plasma Derived Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Plasma Derived Drugs Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Plasma Derived Drugs Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Plasma Derived Drugs
Table 68. Key Market Challenges & Risks of Plasma Derived Drugs
Table 69. Key Industry Trends of Plasma Derived Drugs
Table 70. Plasma Derived Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Plasma Derived Drugs Distributors List
Table 73. Plasma Derived Drugs Customer List
Table 74. Global Plasma Derived Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Plasma Derived Drugs Sales Market Forecast by Region
Table 76. Global Plasma Derived Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Plasma Derived Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Plasma Derived Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Plasma Derived Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Plasma Derived Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Plasma Derived Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Plasma Derived Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Plasma Derived Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Plasma Derived Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Plasma Derived Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Plasma Derived Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Plasma Derived Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Plasma Derived Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Plasma Derived Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Plasma Derived Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Plasma Derived Drugs Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Plasma Derived Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Plasma Derived Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 94. Grifols, S.A. Basic Information, Plasma Derived Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Grifols, S.A. Plasma Derived Drugs Product Offered
Table 96. Grifols, S.A. Plasma Derived Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Grifols, S.A. Main Business
Table 98. Grifols, S.A. Latest Developments
Table 99. Octapharma Basic Information, Plasma Derived Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Octapharma Plasma Derived Drugs Product Offered
Table 101. Octapharma Plasma Derived Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Octapharma Main Business
Table 103. Octapharma Latest Developments
Table 104. Antares Pharma Basic Information, Plasma Derived Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Antares Pharma Plasma Derived Drugs Product Offered
Table 106. Antares Pharma Plasma Derived Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Antares Pharma Main Business
Table 108. Antares Pharma Latest Developments
Table 109. CSL Limited Basic Information, Plasma Derived Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. CSL Limited Plasma Derived Drugs Product Offered
Table 111. CSL Limited Plasma Derived Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. CSL Limited Main Business
Table 113. CSL Limited Latest Developments
List of Figures
Figure 1. Picture of Plasma Derived Drugs
Figure 2. Plasma Derived Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma Derived Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Plasma Derived Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Plasma Derived Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Immunoglobulins
Figure 10. Product Picture of Albumins
Figure 11. Product Picture of Clotting Factors
Figure 12. Product Picture of Others
Figure 13. Global Plasma Derived Drugs Sales Market Share by Type in 2021
Figure 14. Global Plasma Derived Drugs Revenue Market Share by Type (2017-2022)
Figure 15. Plasma Derived Drugs Consumed in Hospitals
Figure 16. Global Plasma Derived Drugs Market: Hospitals (2017-2022) & (K Units)
Figure 17. Plasma Derived Drugs Consumed in Speciality Clinics
Figure 18. Global Plasma Derived Drugs Market: Speciality Clinics (2017-2022) & (K Units)
Figure 19. Plasma Derived Drugs Consumed in Ambulatory Surgical Centers
Figure 20. Global Plasma Derived Drugs Market: Ambulatory Surgical Centers (2017-2022) & (K Units)
Figure 21. Plasma Derived Drugs Consumed in Diagnostic Centers
Figure 22. Global Plasma Derived Drugs Market: Diagnostic Centers (2017-2022) & (K Units)
Figure 23. Plasma Derived Drugs Consumed in Others
Figure 24. Global Plasma Derived Drugs Market: Others (2017-2022) & (K Units)
Figure 25. Global Plasma Derived Drugs Sales Market Share by Application (2017-2022)
Figure 26. Global Plasma Derived Drugs Revenue Market Share by Application in 2021
Figure 27. Plasma Derived Drugs Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Plasma Derived Drugs Revenue Market Share by Company in 2021
Figure 29. Global Plasma Derived Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Plasma Derived Drugs Revenue Market Share by Geographic Region in 2021
Figure 31. Global Plasma Derived Drugs Sales Market Share by Region (2017-2022)
Figure 32. Global Plasma Derived Drugs Revenue Market Share by Country/Region in 2021
Figure 33. Americas Plasma Derived Drugs Sales 2017-2022 (K Units)
Figure 34. Americas Plasma Derived Drugs Revenue 2017-2022 ($ Millions)
Figure 35. APAC Plasma Derived Drugs Sales 2017-2022 (K Units)
Figure 36. APAC Plasma Derived Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Europe Plasma Derived Drugs Sales 2017-2022 (K Units)
Figure 38. Europe Plasma Derived Drugs Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Plasma Derived Drugs Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa Plasma Derived Drugs Revenue 2017-2022 ($ Millions)
Figure 41. Americas Plasma Derived Drugs Sales Market Share by Country in 2021
Figure 42. Americas Plasma Derived Drugs Revenue Market Share by Country in 2021
Figure 43. United States Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Plasma Derived Drugs Sales Market Share by Region in 2021
Figure 48. APAC Plasma Derived Drugs Revenue Market Share by Regions in 2021
Figure 49. China Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Plasma Derived Drugs Sales Market Share by Country in 2021
Figure 56. Europe Plasma Derived Drugs Revenue Market Share by Country in 2021
Figure 57. Germany Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Plasma Derived Drugs Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Plasma Derived Drugs Revenue Market Share by Country in 2021
Figure 64. Egypt Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Plasma Derived Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Plasma Derived Drugs in 2021
Figure 70. Manufacturing Process Analysis of Plasma Derived Drugs
Figure 71. Industry Chain Structure of Plasma Derived Drugs
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...